Tuesday, November 19, 2019
Investigator(s): Matthew Budoff, MD
Research Theme(s): Metabolic Diseases, Women's and Children's Health
PHILADELPHIA — Findings from a new study provide a promising pathway toward reducing the impact of heart disease, as the data shows that Vascepa, a drug derived from omega-3 oils that is commonly used to treat hypertriglyceridemia, a disease that causes elevated fat levels in blood, also reduces the progression of heart disease.
Wednesday, November 13, 2019
Investigator(s): Margaret Keller, MD, Richard Casaburi, PhD, MD
Research Theme(s): Infection and Immunity
LOS ANGELES – The Lundquist Institute, one of the nation’s leading nonprofit biomedical research institutes, hosted its 16th Annual Legends celebration on November 12 honoring two highly distinguished researchers for their groundbreaking innovations and outstanding service in finding solutions to the most pressing medical problems of our day.
Wednesday, November 13, 2019
Investigator(s): Margaret Keller, MD, Richard Casaburi, PhD, MD
Research Theme(s): Respiratory Medicine and Exercise Physiology
LOS ANGELES – The Lundquist Institute, one of the nation’s leading nonprofit biomedical research institutes, hosted its 16th Annual Legends celebration on November 12 honoring two highly distinguished researchers for their groundbreaking innovations and outstanding service in finding solutions to the most pressing medical problems of our day.
Wednesday, November 6, 2019
Investigator(s): Virender Rehan, MD
Research Theme(s): Respiratory Medicine and Exercise Physiology, Women's and Children's Health
LOS ANGELES — E-cigarette use, or vaping, can damage lungs in as little as three days of use, according to a new study from The Lundquist Institute (formerly known as LA BioMed) and the University of Rochester.